Summit X LLC’s Sanofi SNY Stock Holding History

Summit X LLC’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,189	Closed	-$356K	–	228
2024 Q2	$356K	Buy	+7,189	New	+$347K	0.08%	155
2023 Q3	–	Sell	-6,290	Closed	-$339K	–	262
2023 Q2	$339K	Buy	6,290 +175	+3%	+$9.42K	0.08%	199
2023 Q1	$334K	Buy	+6,115	New	+$297K	0.09%	197

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Summit X LLC's SNY Position: Q3 2024 in Review

Summit X LLC sold out of Sanofi (SNY) in Q3 2024, closing a stake of 7,189 shares — an estimated $356K sold.

Summit X LLC first reported a position in SNY in Q1 2023 and held it in 3 quarters. The position peaked at $356K in Q2 2024. 758 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

Summit X LLC reported no remaining Sanofi position as of Q3 2024 after selling out during the quarter.
Summit X LLC sold 7,189 Sanofi shares in Q3 2024, an estimated $356K.
Summit X LLC first reported a position in Sanofi in Q1 2023 and held it in 3 quarters.
Summit X LLC's Sanofi position peaked at $356K in Q2 2024.
758 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Summit X LLC's 13F filing for Q3 2024, filed 7 Nov 2024.